These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26346287)

  • 1. Role of Inositol Phosphosphingolipid Phospholipase C1, the Yeast Homolog of Neutral Sphingomyelinases in DNA Damage Response and Diseases.
    Tripathi K
    J Lipids; 2015; 2015():161392. PubMed ID: 26346287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
    Matmati N; Hannun YA
    J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelinases and Liver Diseases.
    Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae.
    Sawai H; Okamoto Y; Luberto C; Mao C; Bielawska A; Domae N; Hannun YA
    J Biol Chem; 2000 Dec; 275(50):39793-8. PubMed ID: 11006294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
    Wu BX; Clarke CJ; Hannun YA
    Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingomyelinases in cell regulation.
    Liu B; Obeid LM; Hannun YA
    Semin Cell Dev Biol; 1997 Jun; 8(3):311-322. PubMed ID: 10024495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid metabolism and neutral sphingomyelinases.
    Airola MV; Hannun YA
    Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.
    Pavoine C; Pecker F
    Cardiovasc Res; 2009 May; 82(2):175-83. PubMed ID: 19176603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
    Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
    Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral Sphingomyelinases in Cancer: Friend or Foe?
    Clarke CJ
    Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of sphingomyelinases in neurological disorders.
    Ong WY; Herr DR; Farooqui T; Ling EA; Farooqui AA
    Expert Opin Ther Targets; 2015; 19(12):1725-42. PubMed ID: 26243307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
    Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
    Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of host sphingomyelin is essential for Leishmania virulence.
    Zhang O; Wilson MC; Xu W; Hsu FF; Turk J; Kuhlmann FM; Wang Y; Soong L; Key P; Beverley SM; Zhang K
    PLoS Pathog; 2009 Dec; 5(12):e1000692. PubMed ID: 20011126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral sphingomyelinase as a target for drug design.
    Wascholowski V; Giannis A
    Drug News Perspect; 2001 Dec; 14(10):581-90. PubMed ID: 12806424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neutral sphingomyelinase family: identifying biochemical connections.
    Clarke CJ; Wu BX; Hannun YA
    Adv Enzyme Regul; 2011; 51(1):51-8. PubMed ID: 21035485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An acidic sphingomyelinase Type C activity from Mycobacterium tuberculosis.
    Castro-Garza J; González-Salazar F; Quinn FD; Karls RK; De La Garza-Salinas LH; Guzmán-de la Garza FJ; Vargas-Villarreal J
    Rev Argent Microbiol; 2016; 48(1):21-6. PubMed ID: 26948102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling sphingomyelinases: which, where, how and why?
    Levade T; Jaffrézou JP
    Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Therapeutic Landscape of Sphingomyelinases.
    Shanbhogue P; Hannun YA
    Handb Exp Pharmacol; 2020; 259():19-47. PubMed ID: 30478737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide signalling and the immune response.
    Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
    Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
    Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
    Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.